N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺
中文别名:
N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺N-METHYL-N-[(3R,4R)-4-METHYL-1-(PHENYLMETHYL)-3-PIPERIDINYL]- 7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE;托法杂质M-RR;(3R,4R)-(1-苄基-4-甲基-哌啶-3-基)-甲基-(7H-吡咯并[2,3-D]嘧啶-4-基)-胺;托伐替尼杂质D;N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺;N-((3R,4R)-1-苄基-4-甲基哌啶-3-基)-N-甲基-7H-吡咯[2,3-D]嘧啶-4-胺;托法替尼杂质 1;N-((3R,4R)-1-苄基-4-甲基哌啶-3-基)-N-甲基-7H-吡咯并[2,3-D]嘧啶-4-胺
英文名称:
N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺
英文别名:
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-;1H-Pyrrolo[2,3-d]pyriMidin-4-aMine,N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-;N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;Tasocitinib Intermediate;-1-Benzyl-4-methylpiperidin-3-yl);N-((3R,4R);N-((3R,4R)-1-BENZYL-4-METHYLPIPERIDIN-3-YL)-N-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-;Tofacitinib impurity 6/N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
密度:
1.205±0.06 g/cm3(Predicted)